Table 6.
Comparative analysis on costs per QALY
| POLYMOD | Roxanne | CoRoVa | |
|---|---|---|---|
| Health-care perspective | |||
| Afr | $ 265a | $ 188-367b | $ 233-440 b |
| Sear | $ 358a | $ 257-503b | $ 308-591 b |
| Amr | $ 307a | $ 200-652b | $ 336-862 b |
| Eur | € 57,897 | € 50,999 | € 56,656 |
| Societal perspective | |||
| Afr | $ 260a | $ 185-364 b | $ 231-438 b |
| Sear | $ 328a | $ 241-487 b | $ 293-577 b |
| Amr | $ 196a | $ 143-595 b | $ 282-809 b |
| Eur | € 49,427 | € 40,041 | € 44,263 |
a. based on future reduction of vaccine prices from $7.5 to $4; b. Range given for previous upper and lower vaccine prices